Multifunctional Magnetic Nanoplatform Eliminates Cancer Stem Cells via Inhibiting the Secretion of Extracellular Heat Shock Protein 90.
Animals
Antibodies
/ chemistry
Apoptosis
/ drug effects
Benzoquinones
/ chemistry
Cell Line, Tumor
Ferrosoferric Oxide
/ chemistry
HSP90 Heat-Shock Proteins
/ antagonists & inhibitors
Humans
Hyaluronan Receptors
/ immunology
Hyperthermia, Induced
Lactams, Macrocyclic
/ chemistry
Magnetite Nanoparticles
/ chemistry
Mice
Neoplasms
/ drug therapy
Neoplastic Stem Cells
/ cytology
Porosity
Signal Transduction
/ drug effects
Silicon Dioxide
/ chemistry
Transplantation, Heterologous
cancer stem cells
extracellular heat shock protein 90
multifunctional nanoparticles
signaling pathways
thermotherapy and chemotherapy
Journal
Advanced healthcare materials
ISSN: 2192-2659
Titre abrégé: Adv Healthc Mater
Pays: Germany
ID NLM: 101581613
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
05
02
2019
revised:
16
03
2019
pubmed:
11
4
2019
medline:
13
8
2020
entrez:
11
4
2019
Statut:
ppublish
Résumé
Cancer stem cells (CSCs) are responsible for malignant tumor initiation, recurrences, and metastasis. Therefore, targeting CSCs is a promising strategy for the development of cancer therapies. A big challenge for CSC-based cancer therapy is the overexpression of therapeutic stress protein, heat shock protein 90 (Hsp90), which protects CSCs from further therapeutic-induced damage, leading to the failure of treatment. Thus, efficient strategies to target CSCs are urgently needed for cancer therapy. To this end, a multifunctional nanoparticle (MNP) for CSC-based combined thermotherapy and chemotherapy is reported. This strategy dramatically suppresses tumor growth in breast CSC xenograft-bearing mice. Furthermore, a new mechanism is present that the MNP exerts its striking effects on CSCs by inhibiting the secretion of extracellular Hsp90 (eHsp90), resulting in the interruption of several key signaling pathways. These findings open new perspectives on the use of an MNP for effective CSC-based cancer treatment by inhibiting the function of eHsp90.
Identifiants
pubmed: 30969015
doi: 10.1002/adhm.201900160
doi:
Substances chimiques
Antibodies
0
Benzoquinones
0
HSP90 Heat-Shock Proteins
0
Hyaluronan Receptors
0
Lactams, Macrocyclic
0
Magnetite Nanoparticles
0
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
001L2FE0M3
Silicon Dioxide
7631-86-9
Ferrosoferric Oxide
XM0M87F357
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1900160Subventions
Organisme : National Natural Science Foundation of China
ID : 31500812
Pays : International
Organisme : National Natural Science Foundation of China
ID : 31470961
Pays : International
Organisme : National Natural Science Foundation of China
ID : 21603051
Pays : International
Organisme : National Natural Science Foundation of China
ID : 21601046
Pays : International
Organisme : Natural Science Foundation of Hebei Province
ID : B2017201230
Pays : International
Organisme : Natural Science Foundation of Hebei Province
ID : B2017201226
Pays : International
Organisme : Natural Science Foundation of Hebei Province
ID : B208201221
Pays : International
Organisme : Natural Science Foundation of Hebei Province
ID : B2017201135
Pays : International
Organisme : Fund Program for the Scientific Activities of Selected Returned Overseas Professionals
ID : CG2015003009
Pays : International
Organisme : Science and Technology Research Project of Higher Education Institutions in Hebei Province
ID : QN2015230
Pays : International
Organisme : Post-graduate's Innovation Fund Project of Hebei University
ID : hbu2018ss18
Pays : International
Informations de copyright
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.